BIOLIFE SOLUTIONS INC (BLFS) 8-K Current Report — March 2, 2026
Filed: March 2, 2026
Health Care
Electromedical & Electrotherapeutic ApparatusBIOLIFE SOLUTIONS INC (BLFS) 8-K current report filed with SEC EDGAR on March 2, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 7.01: Regulation FD Disclosure
BIOLIFE SOLUTIONS INC 8-K Mar 2, 2026 Event Analysis
Item 7.01 · Regulation FD Disclosure
- • Reg FD filing signals BioLife (BLFS) is actively communicating strategic/financial updates to the investment community
- • Investor presentation dated Feb 26, 2026, published March 2, 2026 — full content in Exhibit 99.1 and on IR website
Other BIOLIFE SOLUTIONS INC 8-K Filings
Get deeper insights on BIOLIFE SOLUTIONS INC
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.